← Leaderboards
Nicholas Antonios Kalogriopoulos
University Of California, San Diego
$301,689
Attributed
$301,689
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $71.8K · FY2017–23$100K$75K$50K$25K$0
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$301,689 · 2
By mechanism
F32$205,368 · 1
F31$96,321 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California, San Diego
Same institution · by research overlap
- Pradipta Ghosh$13,342,507
- Adam J Engler$11,532,016
- Tracy M Handel$22,625,305
- Timothy Charles Rodwell$12,115,545
- Murray B. Stein$36,454,107
Others in their field
Other Emerging Leaders on “Binding”
- Xinhua Li · Nano Terra, Inc.$35,520,438
- John Damon Chodera · Sloan-Kettering Inst Can Research$21,305,909
- Tharick Pascoal · University Of Pittsburgh At Pittsburgh$20,465,582
- Suzanne L Baker · University Of Pittsburgh At Pittsburgh$20,465,582
- Kristian Graugaard Andersen · Scripps Research Institute, The$18,732,618
- Steven Armen Boyd · Venatorx Pharmaceuticals, Inc.$13,685,544
Research focus
BindingG-Protein-Coupled ReceptorsReceptor ActivationCellsMembraneExperimental StudyMalignant NeoplasmsReceptorSignal TransductionTumorCell BehaviorNeoplastic CellB Lymphoid MalignancyBiomedical EngineeringAttentionDisease RemissionAntigensDrug RegulationsEngineeringChimeric Antigen ReceptorCytokine Release SyndromeCytokineChimeric Antigen Receptor T CellsDangerousness
Grant awards (6)
Bioengineering programmable and drug-controllable synthetic receptors fortunable CAR-T cell behaviors$71,792
F32 · FY2023 · CA · contact PI
Bioengineering programmable and drug-controllable synthetic receptors fortunable CAR-T cell behaviors$67,582
F32 · FY2022 · CA · contact PI
Bioengineering programmable and drug-controllable synthetic receptors fortunable CAR-T cell behaviors$65,994
F32 · FY2021 · CA · contact PI
Trimeric G proteins as Novel Targets in Cancer Progression$24,051
F31 · FY2019 · CA · contact PI
Trimeric G proteins as Novel Targets in Cancer Progression$36,375
F31 · FY2018 · CA · contact PI
Trimeric G proteins as Novel Targets in Cancer Progression$35,895
F31 · FY2017 · CA · contact PI